2m 2m 2m 2m 2m 2m 2m
CV Sciences (CVSI)
OTC
$0.010+$0.0002 (+1.82%)
Price as of Nov 11, 2026- $2.1MMarket Cap
- -71.15%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CV Sciences (CVSI)
$0.010+$0.0002 (+1.82%)
CVSI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.01 | ||
Change | +$0.0002 (+1.82%) | ||
Open | $0.01 | ||
High | $0.01 | ||
Low | $0.01 | ||
Previous Close | $0.01 | ||
Volume | 523,559 | ||
30-Day Average Volume | 901,730 | ||
1-Week Change | -4.80% | ||
1-Month Change | -32.00% | ||
1-Year Change | -71.15% | ||
3-Year Change | -73.92% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 225.8M | ||
Total Assets | $6.5M | ||
Market Cap | $2.1M | ||
Enterprise Value | $1.9M | ||
Period: QTR TTM FY | |||
Revenue | $3.0M | ||
Net Income | -$775,000.00 | ||
Free Cash Flow | $13,000.00 | ||
EBIT | -$770,000.00 | ||
EBITDA | -$748,000.00 | ||
Net Working Capital | -$64,000.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 1 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 165 | ||
Price/Operating Cash Flow | 107 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue